Sign inJoin waitlistJoin the waitlist

Jason Fixler

Pediatric Hematology-Oncology · The Children's Hosp. at Sinai

Credentials: · · · ·

History

The Children's Hosp. at Sinai
Present

Children's Hospital Med. Ctr.-Northern CA
1999–2000
University of Illinois Hosp. & Clini
1996–1999
University of Illinois College of Medicine
1992–1996

Research

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
New England Journal of Medicine · 2014 · 406 citations
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
Blood · 2012 · 164 citations
Silent cerebral infarction, income, and grade retention among students with sickle cell anemia
American Journal of Hematology · 2014 · 78 citations

Alexis Thompson
4 papers
Beng Fuh
4 papers
Charles Quinn
4 papers
JC
James Casella
4 papers
SS
Sharada Sarnaik
4 papers
Allison King
3 papers · 3 as a resident
GW
Gerald Woods
3 papers
John Strouse
3 papers
JP
Julie Panepinto
3 papers
KK
Karen Kalinyak
3 papers
MH
Mark Heiny
3 papers
Melissa Mcnaull
3 papers

Clinical trials

Quality of End-of-Life Care for Children With Cancer
Site PI · Recruiting
Children's Oncology Group
2026–2031
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030